Algert Global LLC Sage Therapeutics, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 143,034 shares of SAGE stock, worth $819,584. This represents 0.03% of its overall portfolio holdings.

Number of Shares

143,034

Previous 64,844 120.58%

Holding current value

$819,584

Previous $704,000 46.73%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.02 - $13.08 $548,893 - $1.02 Million	78,190 Added 120.58%	143,034 $1.03 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $413,826 - $700,140	39,114 Added 152.02%	64,844 $704,000
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $529,416 - $689,169	-30,960 Reduced 54.61%	25,730 $558,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $949,557 - $2.78 Million	56,690 New	56,690 $1.17 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $46.57 $403,894 - $504,679	-10,837 Reduced 43.15%	14,280 $599,000
Q4 2022 Feb 13, 2023	SELL	$32.2 - $43.61 $274,344 - $371,557	-8,520 Reduced 25.33%	25,117 $958,000
Q3 2022 Nov 15, 2022	SELL	$32.28 - $43.27 $1.26 Million - $1.69 Million	-39,112 Reduced 53.76%	33,637 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $1.49 Million - $2.05 Million	54,077 Added 289.62%	72,749 $2.35 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $377,610 - $562,050	12,296 Added 192.85%	18,672 $618,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $38,542 - $48,994	1,040 Added 19.49%	6,376 $271,000
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $214,827 - $306,126	5,336 New	5,336 $236,000
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $516,451 - $707,315	-7,310 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $1.23 Million - $1.88 Million	-21,121 Reduced 74.29%	7,310 $632,000
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $1.18 Million - $1.79 Million	-28,727 Reduced 50.26%	28,431 $1.74 Million
Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $607,022 - $1.01 Million	23,392 Added 69.28%	57,158 $2.38 Million
Q1 2020 May 13, 2020	BUY	$26.15 - $77.24 $882,980 - $2.61 Million	33,766 New	33,766 $970,000

Others Institutions Holding SAGE

# of Institutions

218

Shares Held

46.4M

Call Options Held

847K

Put Options Held

188K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Sage Therapeutics, Inc. Transaction History